In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


The Artificial Pancreas: A Race To The Finish

Executive Summary

The first fully functional artificial pancreas for patients with diabetes could be ready for regulatory submission in the next few years. Medtronic has achieved notable success in this area to date, but positive clinical studies have put J&J in a good position as well, and the medical community is watching closely as the major developments in this groundbreaking endeavor continue to move forward.


Related Content

FDA Approves Animas’ Vibe Linking Insulin Pump With DexCom CGM
Novo Nordisk Launches Cartridges For Roche Insulin Pumps
Medtronic, Aetna Partner On Insulin Pump Cost-Savings Program
DexCom Hit With FDA Warning Letter For Adverse Event Deficiencies
Novel Insulin Delivery Systems Pump New Life Into Diabetes Device Market
MannKind Gears Up To Make Commercial Case For Inhaled Insulin Afrezza
Medicare Durable Equipment Cuts Will Deepen In Next Round Of Competitive Bidding
Artificial Pancreas Guidance Allows For More Flexibility In Trial Design
Cautious FDA Is Obstacle For Burgeoning Diabetes Device Market


Related Companies




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts